Stay updated on Daratumumab Combo in Resistant Myeloma Clinical Trial
Sign up to get notified when there's something new on the Daratumumab Combo in Resistant Myeloma Clinical Trial page.
Latest updates to the Daratumumab Combo in Resistant Myeloma Clinical Trial page
- CheckyesterdayNo Change Detected
- Check9 days agoChange DetectedThe website has been updated from version 2.10.2 to 2.10.3, indicating a new release.SummaryDifference0.1%
- Check16 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe website has been updated from version 2.10.0 to 2.10.2, indicating new features or improvements.SummaryDifference0.1%
- Check51 days agoChange DetectedThe study has expanded to include 41 locations, and the website has been updated to version v2.10.0, replacing the previous version v2.9.7.SummaryDifference0.3%
- Check59 days agoChange DetectedThe website has been updated to Revision v2.9.7 from v2.9.6.SummaryDifference0.1%
- Check72 days agoChange DetectedThe value of Revision has been updated from v2.9.5 to v2.9.6, indicating a recent revision in the content of the web page.SummaryDifference0.1%
- Check77 days agoChange DetectedThe value of Revision has been updated from v2.9.3 to v2.9.5, indicating a recent change in the webpage content related to the study of Daratumumab in Combination With Dexamethasone in Resistant or Refractory Multiple Myeloma, showing ongoing updates and revisions to the study details.SummaryDifference0.1%
Stay in the know with updates to Daratumumab Combo in Resistant Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Daratumumab Combo in Resistant Myeloma Clinical Trial page.